FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

37850011000036107: natalizumab 300 mg / 15 mL injection, 15 mL vial (medicinal product unit of use)

Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
286600011000036111 natalizumab 300 mg/15 mL injection, vial en Synonym Active Case sensitive Australian Medicines Terminology module
286602011000036110 natalizumab 300 mg / 15 mL injection, 15 mL vial (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
natalizumab 300 mg/15 mL injection, vial Is a medicinal product unit of use true Inferred relationship Some
natalizumab 300 mg/15 mL injection, vial Is a natalizumab true Inferred relationship Some
natalizumab 300 mg/15 mL injection, vial has intended active ingredient natalizumab true Inferred relationship Some 2055641374
natalizumab 300 mg/15 mL injection, vial has Australian BoSS natalizumab true Inferred relationship Some 2055641374
natalizumab 300 mg/15 mL injection, vial has manufactured dose form injection true Inferred relationship Some
natalizumab 300 mg/15 mL injection, vial has unit of use vial true Inferred relationship Some 2055641375
Inbound Relationships Type Active Source Characteristic Refinability Group
Tysabri 300 mg/15 mL injection, 15 mL vial Is a True natalizumab 300 mg/15 mL injection, vial Inferred relationship Some
natalizumab 300 mg/15 mL injection, 15 mL vial has MPUU True natalizumab 300 mg/15 mL injection, vial Inferred relationship Some 1

Reference Sets

Medicinal product unit of use reference set

Back to Start